Conexeu Sciences Inc
CNXU
7 hedge funds and large institutions have $278K invested in Conexeu Sciences Inc in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.1% more ownership
Funds ownership: 0% → 0.1% (+0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$158K |
| 2 |
Morgan Stanley
New York
|
+$75.5K |
| 3 |
Citigroup
New York
|
+$67.1K |
| 4 |
HCM
Hollencrest Capital Management
Newport Beach,
California
|
+$12.9K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$11.4K |
Top Sellers
CNXU Hedge Fund Activity: Q2 2026 in Review
7 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Conexeu Sciences Inc (CNXU) for Q2 2026, worth a combined $278K.
Buyers outnumbered sellers: 7 funds opened new CNXU positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $158K.
- 7 institutional investors held Conexeu Sciences Inc (CNXU) as of Q2 2026, up from 0 in Q1 2026.
- Funds reported $278K of Conexeu Sciences Inc stock for Q2 2026.
- 7 funds opened new Conexeu Sciences Inc positions in Q2 2026 and 0 closed out, a net change of +7 holders.
- The largest Conexeu Sciences Inc buyer in Q2 2026 was UBS Group, an estimated $158K added.
Based on aggregated 13F filings for Q2 2026.